Antimicrobial prodrug activation by the staphylococcal glyoxalase GloB
M. O. Mikati, J. J. Miller, D. M. Osbourn, N. Ghebremichael, I. T. Shah, C.-A. D. Burnham, K. M. Heidel, V. C. Yan, F. L. Mueller, C. S. Dowd, R. L. Edwards, A. R. Odom John
This study identifies GloB as a bacterial enzyme that activates carboxy ester prodrugs, suggesting its potential for developing targeted prodrug therapies against staphylococcal species.
ACS Infectious Diseases · Oct 29, 2020Peer-reviewedMicrobiology